US$ 22.99
glutathione for parkinson's disease 2020 Disease: Bridging Gaps, Building Biomarkers, and Reimagining Clinical Translation Targeting Ferroptosis in Parkinson's Disease:
Description
Sharkey and O'Neill, 2019)

Tolerability and feasibility of at-home remotely supervised transcranial direct current stimulation (RS-tDCS): single-center evidence from 6,779 sessions

They are effective and cause minimal side effects

10.1124/jpet.104.078469 127 LeeE
